News

Following a summer of community engagement in the Shaun in the Heart of Kent art trail; Bedfont® awards a prize for finding ‘Shorn the Return’. Bedfont® Scientific Ltd., a world leader in breath analysis with over 47 years of expertise...

Double Victory for Bedfont®: Crowned ‘Medium Business of the Year 2024 and ‘Best of Kent’. Bedfont®, located in Harrietsham, Kent, has over 48 years of expertise in designing and manufacturing medical breath analysis devices. Bedfont® was delighted to win Medium...

Hydrogen-methane breath testing (HMBT) is a widely used, non-invasive method to diagnose conditions such as small intestinal bacterial overgrowth (SIBO) and carbohydrate malabsorption (e.g. lactose intolerance). The accuracy of HMBT results depends heavily on proper quality controls, accurate calibration, appropriate...

NObreath® FeNO device and Gastrolyzer® range of devices are now available across the Middle East. Bedfont® Scientific Limited, a world leader in breath analysis with over 47 years of knowledge and expertise in designing and manufacturing medical breath analysis devices,...

On Wednesday, 27th November, the National Institute for Health and Care Excellence (NICE), the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN) updated and published a joint guideline on asthma diagnosis, monitoring, and chronic asthma management.  Streamlining...

Bedfont® outlines key updates and offers support for healthcare professionals navigating the changes. Bedfont® Scientific Ltd., world leaders in breath analysis with over 47 years of knowledge in designing and manufacturing medical breath analysis devices, welcomes the recent update to...